{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:18:33Z","timestamp":1794953913988,"version":"4.9.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116980","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:40:25Z","timestamp":1785184825000},"page":"116980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Essentiality-driven prediction of anticancer drug responses in preclinical and clinical contexts"],"prefix":"10.1016","volume":"29","author":[{"given":"Hongtu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Biao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116980_bib1","first-page":"229","article-title":"Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116980_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116980_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55251-5","article-title":"Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116980_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116980_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41590-024-01789-x","article-title":"A method for predicting drugs that can boost the efficacy of immune checkpoint blockade","volume":"25","author":"Xia","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.116980_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","article-title":"Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship","volume":"20","author":"Lustberg","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116980_bib7","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Targeting grp75 with a chlorpromazine derivative inhibits endometrial cancer progression through grp75-ip3r-ca (2+)-ampk axis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.116980_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","article-title":"Drug repurposing for cancer therapy","volume":"9","author":"Xia","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.isci.2026.116980_bib9","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.116980_bib10","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.3390\/ijms24086926","article-title":"Unveiling the genomic basis of chemosensitivity in sarcomas of the extremities: an integrated approach for an unmet clinical need","volume":"24","author":"Vanni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116980_bib11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116980_bib12","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (gdsc): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116980_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.116980_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the cancer dependency map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116980_bib15","doi-asserted-by":"crossref","first-page":"W502","DOI":"10.1093\/nar\/gkaa327","article-title":"Paccmann: a web service for interpretable anticancer compound sensitivity prediction","volume":"48","author":"Cadow","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116980_bib16","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1038\/s41467-022-33291-z","article-title":"Gene expression based inference of cancer drug sensitivity","volume":"13","author":"Chawla","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116980_bib17","article-title":"Deepccds: interpretable deep learning framework for predicting cancer cell drug sensitivity through characterizing cancer driver signals","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.116980_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10916-025-02182-3","article-title":"Mlg2net: molecular global graph network for drug response prediction in lung cancer cell lines","volume":"49","author":"Tran","year":"2025","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.isci.2026.116980_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh1275","article-title":"Predicting and characterizing a cancer dependency map of tumors with deep learning","volume":"7","author":"Chiu","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.116980_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s43588-024-00733-1","article-title":"Comprehensive prediction and analysis of human protein essentiality based on a pretrained large language model","volume":"5","author":"Kang","year":"2025","journal-title":"Nat. Comput. Sci."},{"key":"10.1016\/j.isci.2026.116980_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57116","article-title":"Shinydepmap, a tool to identify targetable cancer genes and their functional connections from cancer dependency map data","volume":"10","author":"Shimada","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.116980_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbad003","article-title":"Droeg: a method for cancer drug response prediction based on omics and essential genes integration","volume":"24","author":"Wu","year":"2023","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.isci.2026.116980_bib23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: l1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116980_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41420-020-0292-1","article-title":"Amg-232 sensitizes high mdm2-expressing tumor cells to t-cell-mediated killing","volume":"6","author":"Sahin","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2026.116980_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41573-023-00723-4","article-title":"Trends in the approval of cancer therapies by the fda in the twenty-first century","volume":"22","author":"Scott","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.116980_bib26","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1038\/s41467-025-59917-6","article-title":"Deepdtagen: a multitask deep learning framework for drug-target affinity prediction and target-aware drugs generation","volume":"16","author":"Shah","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116980_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: lessons from gnomad","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.isci.2026.116980_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-024-07556-0","article-title":"A deep catalogue of protein-coding variation in 983,578 individuals","volume":"631","author":"Sun","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116980_bib29","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41467-024-48441-8","article-title":"Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression","volume":"15","author":"Park","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116980_bib30","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41467-025-60894-z","article-title":"Hepatitis b virus promotes liver cancer by modulating the immune response to environmental carcinogens","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116980_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116980_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41586-023-06676-3","article-title":"Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells","volume":"623","author":"Doshi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116980_bib33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41586-024-08509-3","article-title":"Ski complex loss renders 9p21.3-deleted or msi-h cancers dependent on pelo","volume":"638","author":"Borck","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116980_bib34","doi-asserted-by":"crossref","first-page":"D998","DOI":"10.1093\/nar\/gkaa884","article-title":"Ogee v3: online gene essentiality database with increased coverage of organisms and human cell lines","volume":"49","author":"Gurumayum","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116980_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168444","article-title":"Essential genes embody increased mutational robustness to compensate for the lack of backup genetic redundancy","volume":"11","author":"Cohen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.116980_bib36","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/s41588-025-02222-1","article-title":"The synthetic lethal interaction between cds1 and cds2 is a vulnerability in uveal melanoma and across multiple tumor types","volume":"57","author":"Chan","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116980_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf266","article-title":"Systematic identification of cancer-type-specific drugs based on essential genes and validations in lung adenocarcinoma","volume":"26","author":"Lian","year":"2025","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.isci.2026.116980_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae688","article-title":"Deepdr: a deep learning library for drug response prediction","volume":"40","author":"Jiang","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116980_bib39","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/jm1001265","article-title":"Bi-97c1, an optically pure apogossypol derivative as pan-active inhibitor of antiapoptotic b-cell lymphoma\/leukemia-2 (bcl-2) family proteins","volume":"53","author":"Wei","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.116980_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4613-1747-0_5","article-title":"Current status of trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties","volume":"42","author":"Lin","year":"1989","journal-title":"Cancer Treat Res."},{"key":"10.1016\/j.isci.2026.116980_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/13816128113199990470","article-title":"Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles","volume":"20","author":"Tang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.isci.2026.116980_bib42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/1389450117666160301095233","article-title":"Polypharmacology of approved anticancer drugs","volume":"18","author":"Amelio","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.isci.2026.116980_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: the science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.116980_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/17425255.2024.2356162","article-title":"Recent progress in machine learning approaches for predicting carcinogenicity in drug development","volume":"20","author":"Le","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.isci.2026.116980_bib45","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-025-60989-7","article-title":"Toxacol: an endpoint-aware and task-focused compound representation learning paradigm for acute toxicity assessment","volume":"16","author":"Lu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116980_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab356","article-title":"A cross-study analysis of drug response prediction in cancer cell lines","volume":"23","author":"Xia","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.isci.2026.116980_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12915-024-02023-8","article-title":"Transcdr: a deep learning model for enhancing the generalizability of drug activity prediction through transfer learning and multimodal data fusion","volume":"22","author":"Xia","year":"2024","journal-title":"BMC Biol."},{"key":"10.1016\/j.isci.2026.116980_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13321-025-00972-y","article-title":"The specification game: rethinking the evaluation of drug response prediction for precision oncology","volume":"17","author":"Codic\u00e8","year":"2025","journal-title":"J. Cheminf."},{"key":"10.1016\/j.isci.2026.116980_bib49","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"Drugbank 6.0: the drugbank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116980_bib50","series-title":"Caret: Classification and Regression Training","first-page":"1503","author":"Kuhn","year":"2015"},{"key":"10.1016\/j.isci.2026.116980_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.32614\/RJ-2019-003","article-title":"Dr4pl: a stable convergence algorithm for the 4 parameter logistic model","volume":"11","author":"An","year":"2019","journal-title":"R J."},{"key":"10.1016\/j.isci.2026.116980_bib52","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.isci.2026.116980_bib53","series-title":"Proceedings of the European conference on computer vision (ECCV)","first-page":"3","article-title":"CBAM: convolutional block attention module","author":"Woo","year":"2018"},{"key":"10.1016\/j.isci.2026.116980_bib54","doi-asserted-by":"crossref","DOI":"10.1088\/1749-4699\/8\/1\/014008","article-title":"Hyperopt: a python library for model selection and hyperparameter optimization","volume":"8","author":"Bergstra","year":"2015","journal-title":"Comput. Sci. Discov."},{"key":"10.1016\/j.isci.2026.116980_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.107","article-title":"Ultrafast one-pass fastq data preprocessing, quality control, and deduplication using fastp","volume":"2","author":"Chen","year":"2023","journal-title":"iMeta"},{"key":"10.1016\/j.isci.2026.116980_bib56","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with hisat2 and hisat-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.116980_bib57","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and samtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116980_bib58","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116980_bib59","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for rna-seq data with deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.116980_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for rna-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116980_bib61","first-page":"2014","article-title":"A package for survival analysis in R","volume":"2","author":"Therneau","year":"2015","journal-title":"R package version"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226023588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226023588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:04:52Z","timestamp":1794953092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226023588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226023588"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116980","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essentiality-driven prediction of anticancer drug responses in preclinical and clinical contexts","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116980"}}